Key takeaways
Orencia (abatacept) and Rituxan (rituximab) are both medications used to treat autoimmune conditions like rheumatoid arthritis (RA), but they work differently and have different uses. Orencia blocks certain proteins to lower inflammation and is available as an injection or infusion. Rituxan targets your B cells and is given only as an infusion. Orencia can be used in children as young as 2 years old for certain conditions, while Rituxan is used for both blood cancers and autoimmune conditions in adults and children as young as 6 months for some conditions. Orencia is typically given once a week or once a month, while Rituxan's dosing can range from weekly to every 6 months depending on the condition. Common side effects of Orencia include headache and dizziness, whereas Rituxan can cause fever, chills, and a higher risk of serious infusion-related reactions. Both medications increase the risk of infections, but Rituxan's risk can last up to a year or more after the last dose.
